Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

Quest Diagnostics Incorporated 13F Holders

DGX Stock Ownership Activity

# of activities:
3
AVG reported price*:
$136.85
Current price*:
+72.86%($236.56)
3 value investing gurus have made changes to the Quest Diagnostics Incorporated (DGX) position according to the gurus' 2022 Q1 SEC quarterly report(s). DGX has been bought (as a new position) by 1 guru(s), the number of DGX shares has been increased by 1, decreased by 1 super investor(s).

Which gurus or hedge funds bought DGX in 2022 Q1?

According to the 2022 Q1 SEC filing(s) Quest Diagnostics Incorporated (DGX) has been bought by 2 gurus / funds: Robert Olstein - Olstein Capital Management (added shares +78.57%) and Richard Pzena - Pzena Investment Management (new buy).
To see more about who is investing in Quest Diagnostics Incorporated (DGX), please go to the DGX ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.